UMIN-CTR Clinical Trial

Recruitment status Terminated
Unique ID issued by UMIN UMIN000016739
Receipt No. R000019428
Scientific Title Investigation into the specific brain network of with anti tumor agents by functional MRI
Date of disclosure of the study information 2015/03/31
Last modified on 2022/09/14 (Ver. 3)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Investigation into the specific brain network of with anti tumor agents by functional MRI
Acronym Investigation into the specific brain network of with anti tumor agents by functional MRI
Scientific Title Investigation into the specific brain network of with anti tumor agents by functional MRI
Scientific Title:Acronym Investigation into the specific brain network of with anti tumor agents by functional MRI
Region
Japan

Condition
Condition lung cancer, breast cancer
Classification by specialty
Chest surgery Breast surgery
Classification by malignancy Malignancy
Genomic information NO

Objectives
Narrative objectives1 Investigation into treatment for patients given bevacizumab with lung or breast cancer an outbreak of cerebral vessel disorders
Basic objectives2 Bio-availability
Basic objectives -Others
Trial characteristics_1 Exploratory
Trial characteristics_2 Pragmatic
Developmental phase Not applicable

Assessment
Primary outcomes Investigation of side effects by anti tumor agents
Key secondary outcomes Concentrations of VEGF

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <
Age-upper limit
90 years-old >
Gender Male and Female
Key inclusion criteria Treatment with anti tumor agents.
Ability to informed consent.
Key exclusion criteria Devices of like pacemakers , plates, artificial joints.
Claustrophobia.
Disorders of audition.
Cerebral vessels disorders.
Target sample size 100

Research contact person
Name of lead principal investigator
1st name
Middle name
Last name RIKA NOGAWA
Organization Wakayama medica school
Division name Anesthegiology
Zip code
Address 811-1, Kimiidera, Wakayama-city, Wakayama JAPAN
TEL 073-447-2300
Email rikan@wakayama-med.ac.jp

Public contact
Name of contact person
1st name
Middle name
Last name RIKA NOGAWA
Organization Wakayama medical school
Division name Anesthegiology
Zip code
Address 811-1, Kimiidera, Wakayama-city, Wakayama JAPAN
TEL 073-447-2300
Homepage URL
Email rikan@wakayama-med.ac.jp

Sponsor
Institute Wakayama medical School
Institute
Department

Funding Source
Organization Wakayama medical school
Organization
Division
Category of Funding Organization Local Government
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization
Address
Tel
Email

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2015 Year 03 Month 31 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Terminated
Date of protocol fixation
2014 Year 02 Month 20 Day
Date of IRB
2015 Year 03 Month 01 Day
Anticipated trial start date
2015 Year 04 Month 01 Day
Last follow-up date
2016 Year 03 Month 31 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information We take functional MRIs of patients with anti tumor agents, search the existences of cerebral vessel disorders.

Management information
Registered date
2015 Year 03 Month 08 Day
Last modified on
2022 Year 09 Month 14 Day


Link to view the page
URL(English) https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000019428